<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2016</study_start_year><condition>Metastatic Colorectal Cancer</condition><disease>Metastatic Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2665403</full_dataset_link><location>China</location><study_start_month>7</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Study on the New Technology of Traditional Chinese Medicine Combined with Molecular Targeted Therapy for the Treatment of Metastatic Colorectal Cancer</name><description>Interventions: The treatment group:Chemotherapy + targeted therapy + HC particles;The control group:Chemotherapy + targeted therapy + placebo particles
Primary outcome(s): Progression-Free-Survival
Study Design: Randomized parallel controlled trial</description><dates><creation>2016-07-15</creation></dates><accession>2665403</accession><cross_references><Chinese Clinical Trial Register>ChiCTR-IOR-16008843</Chinese Clinical Trial Register></cross_references></HashMap>